Annual D&A
$4.09 M
+$269.00 K+7.04%
December 1, 2023
Summary
- As of February 21, 2025, MAZE annual depreciation & amortization is $4.09 million, with the most recent change of +$269.00 thousand (+7.04%) on December 1, 2023.
- During the last 3 years, MAZE annual D&A has risen by +$269.00 thousand (+7.04%).
Performance
MAZE Depreciation And Amortization Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Related metrics
Quarterly D&A
$2.59 M
NaN%
September 1, 2024
Summary
- As of February 21, 2025, MAZE quarterly depreciation & amortization is $2.59 million
Performance
MAZE Quarterly D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Related metrics
TTM D&A
$2.59 M
NaN%
September 1, 2024
Summary
- As of February 21, 2025, MAZE TTM depreciation & amortization is $2.59 million
Performance
MAZE TTM D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Related metrics
MAZE Depreciation And Amortization Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +7.0% | - | - |
| 3 y3 years | +7.0% | - | - |
| 5 y5 years | +7.0% | - | - |
MAZE Depreciation And Amortization Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | -6.6% | -16.7% | at low | -16.7% | at low |
| 5 y | 5-year | at high | -6.6% | -16.7% | at low | -16.7% | at low |
| alltime | all time | at high | -6.6% | -16.7% | at low | -16.7% | at low |
Maze Therapeutics Depreciation And Amortization History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $2.59 M(-16.7%) | $2.59 M(-16.7%) |
| Dec 2023 | $4.09 M | - | - |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2023 | - | $3.11 M | $3.11 M |
| Dec 2022 | $3.82 M | - | - |
FAQ
- What is Maze Therapeutics annual depreciation & amortization?
- What is the all time high annual D&A for Maze Therapeutics?
- What is Maze Therapeutics annual D&A year-on-year change?
- What is Maze Therapeutics quarterly depreciation & amortization?
- What is the all time high quarterly D&A for Maze Therapeutics?
- What is Maze Therapeutics TTM depreciation & amortization?
- What is the all time high TTM D&A for Maze Therapeutics?
What is Maze Therapeutics annual depreciation & amortization?
The current annual D&A of MAZE is $4.09 M
What is the all time high annual D&A for Maze Therapeutics?
Maze Therapeutics all-time high annual depreciation & amortization is $4.09 M
What is Maze Therapeutics annual D&A year-on-year change?
Over the past year, MAZE annual depreciation & amortization has changed by +$269.00 K (+7.04%)
What is Maze Therapeutics quarterly depreciation & amortization?
The current quarterly D&A of MAZE is $2.59 M
What is the all time high quarterly D&A for Maze Therapeutics?
Maze Therapeutics all-time high quarterly depreciation & amortization is $3.11 M
What is Maze Therapeutics TTM depreciation & amortization?
The current TTM D&A of MAZE is $2.59 M
What is the all time high TTM D&A for Maze Therapeutics?
Maze Therapeutics all-time high TTM depreciation & amortization is $3.11 M